Pathological mechanisms of hepatic ischemia-reperfusion injury and stem cell–based therapeutic strategies: Mechanistic insights and translational perspectives
Pathology - Research and Practice · 2026-04 · 280 · 156382
DOI: 10.1016/j.prp.2026.156382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2026-04. Verfasst von Ru Nie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical College of Qinghai University, China; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qinghai University,…. Hauptthemen laut MEDLINE: Reperfusion Injury, Mesenchymal Stem Cell Transplantation, Liver, Liver Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Qinghai Science and Technology Department, Qinghai University, Health Commission of Qinghai Province.
Abstract (Originalsprache)
Hepatic ischemia-reperfusion injury (HIRI) remains a major clinical challenge in liver surgery, transplantation, and trauma, contributing to graft dysfunction and increased morbidity. This review summarizes the complex pathophysiology of HIRI, including metabolic derangements during ischemia, bursts of oxidative stress on reperfusion, and sterile inflammation driven by reactive oxygen species (ROS) and immune-cell activation. It also examines regulated cell death pathways-apoptosis, pyroptosis, necroptosis, and ferroptosis-that interact to create self-reinforcing cycles and further amplify tissue injury.Building on these mechanistic insights, the review highlights emerging therapeutic strategies centered on mesenchymal stem cells (MSCs) and MSC-derived products, including extracellular vesicles (EVs), exosomes, and conditioned medium. MSCs confer protection through immunomodulatory effects, such as promoting macrophage polarization toward anti-inflammatory phenotypes, as well as through cytoprotective mechanisms including antioxidant secretion and mitochondrial transfer. In addition, MSCs support tissue repair by enhancing regenerative responses. Preclinical studies consistently show that MSC-based interventions reduce oxidative stress, inflammation, and cell death. Early clinical trials in liver transplantation further suggest that MSC therapy is safe and may reduce ischemia-associated complications.Finally, this review discusses key translational barriers, including inefficient homing, donor-to-donor variability, and the need for standardized manufacturing and potency assessment. Future directions include MSC preconditioning, EV engineering, and combination approaches with machine perfusion technologies. By integrating mechanistic understanding with therapeutic advances, this review underscores the potential of MSC-based therapies to reshape HIRI management and highlights broader opportunities for regenerative medicine in organ injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Medical College of Qinghai University, China; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qinghai University, China; Key Laboratory of Echinococcosis Research of Qinghai Province,…
- Clinical Medical College of Qinghai University, China.
- Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qinghai University, China; Key Laboratory of Echinococcosis Research of Qinghai Province, China.
- Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qinghai University, China; Key Laboratory of Echinococcosis Research of Qinghai Province, China. Electronic address: zhixin_wang001@sina.com.
- Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Qinghai University, China; Key Laboratory of Echinococcosis Research of Qinghai Province, China. Electronic address: fanhaining@medmail.com.cn.
Förderung
- Qinghai Science and Technology Department
- Qinghai University
- Health Commission of Qinghai Province
Zitieren
APA
Nie, R., Duan, Y., Cao, X., Pang, M., Wang, Z., & Fan, H. (2026). Pathological mechanisms of hepatic ischemia-reperfusion injury and stem cell–based therapeutic strategies: Mechanistic insights and translational perspectives. Pathology - Research and Practice, 280, 156382. https://doi.org/10.1016/j.prp.2026.156382
Vancouver
Nie R, Duan Y, Cao X, Pang M, Wang Z, Fan H. Pathological mechanisms of hepatic ischemia-reperfusion injury and stem cell–based therapeutic strategies: Mechanistic insights and translational perspectives. Pathology - Research and Practice. 2026;280:156382. doi:10.1016/j.prp.2026.156382
BibTeX
@article{Nie2026,
author = {Nie, Ru and Duan, Yunlong and Cao, Xiaoting and Pang, Mingquan and Wang, Zhixin and Fan, Haining},
title = {Pathological mechanisms of hepatic ischemia-reperfusion injury and stem cell–based therapeutic strategies: Mechanistic insights and translational perspectives},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {280},
pages = {156382},
doi = {10.1016/j.prp.2026.156382}
}
EUVIMED